Brändle, Martin (Tecan 201201 Head Corporate Communications + Investor Relations) |
Public Relations Manager / Investor Relations Manager |
Tecan (Group) |
Switzerland |
Bräuchle, Christoph |
n. a. |
LMU Munich (Ludwig-Maximilians-Universität München, University of Munich) |
Germany |
Bräuer, Uwe (Genius Venture Capital GmbH 201309 investment manager of Technologiefonds MV) |
Investment Manager |
Genius Venture Capital GmbH |
Germany |
Bröcker, Rudolf (BRAIN 201507 Head Finance & Controlling) |
Controller (management) |
BRAIN (Group) |
Germany |
Brönnimann, Christian (Dectris 201708 CEO) |
Chief Executive Officer (CEO) |
Dectris Ltd. (CH) |
Switzerland |
Brönstrup, Mark (Helmholtz 201503 Prof + Head of Chemical Biology at HZI) |
Professor |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
Buchanan, Iain (Noxxon 201009– interim CEO before Novexel CEO before Vertex Pharmaceuticals) |
Chief Executive Officer (CEO) |
Noxxon Pharma AG |
Germany |
Buchberger, Bernd (MicroCoat Biotechnologie 201104 Managing Director) |
Managing Director |
MicroCoat Biotechnologie GmbH |
Germany |
Buchbinder, Maurice (CryoTherapeutics 201607 CMO) |
Chief Medical Officer (CMO) |
CryoTherapeutics GmbH |
Germany |
Buchenau, Udo |
n. a. |
Geneworx AG |
Germany |
Buchholz, Bernd (Schleswig-Holstein (govt) 202001 Minister for Economic + Technology Affairs) |
Minister |
Schleswig-Holstein (govt region) |
Germany |
Buchholz, Mirko (PerioTrap Pharmaceuticals 201901– Managing Director) |
Managing Director |
PerioTrap Pharmaceuticals GmbH |
Germany |
Buchholz, Stefan (Evonik 201203 Head Innovation Management at Advanced Intermediates Business Unit) |
n. a. |
Evonik (Group) |
Germany |
Buckel, Peter (SuppreMol 2005–201304 CEO RETIRED 4/12 before atugen CEO + Xantos CEO + founder + Roche Mannheim) |
Chief Executive Officer (CEO) |
Baxter (Group) |
Germany |
Buckland, Terry (Schauenburg 201308– Sales + Service Director at Markes Intl before Agilent + Varian + ABI) |
Sales Manager / Marketing Manager |
Schauenburg (Group) |
United Kingdom (GB) |
Buckle, Isabelle (Institut Pasteur 201607 EVP Technology Transfer + Industrial Partnerships) |
IP Manager |
Institut Pasteur |
France |
Buckman, Paul (Pathway Medical Technologies 201109 CEO) |
Chief Executive Officer (CEO) |
Bayer (Group) |
United States (USA) |
Budd, David (Epistem 201603– CEO before Leica Biosystems + Siemens Healthcare Diagnostics + Bayer Diagnostics) |
Chief Executive Officer (CEO) |
Epistem (Group) |
United Kingdom (GB) |
Buddensiek, Dirk (Baden-Württemberg (govt) 201707 Managing Director of MBG Baden-Württemberg) |
Managing Director |
Baden-Württemberg (govt region) |
Germany |
Buecheler, Uwe (Boehringer 201901 Head of Biopharmaceutical Business Unit) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim (Group) |
Germany |
Buechner, Ton (Akzo Nobel 201511 CEO + Novartis 201602– Board Director PROPOSED) |
Chief Executive Officer (CEO) |
Akzo Nobel (Group) |
Netherlands |
Buehler, Kevin (Novartis 201203 Head of Alcon division) |
President/Director/Head Business Group/Unit/Division |
Novartis (Group) |
Switzerland |
Buesa, Carlos (Oryzon Genomics SA 201404 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Oryzon Genomics (Group) |
Spain (España) |
Bufe, Albrecht (Protectimmun 200808 Founder) |
Company Founder |
Protectimmun GmbH |
Germany |
Buhl, Thomas (Global Bioenergies 201606 Head of Business Development) |
Business Development Manager / Strategy Manager |
Global Bioenergies (Group) |
France |
Buhlmann, Carsten (Eppendorf 201409 International Product Manager) |
Product Manager (personnel) |
Eppendorf (Group) |
Germany |
Buhmann, Raymund (AptaIT GmbH 201707 Managing Director) |
Managing Director |
AptaIT GmbH |
Germany |
Bui, Lynne A. (Khloris Biosciences 201904 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Khloris Biosciences Inc. |
United States (USA) |
Builder, Stuart E. (Coherus 2010– Co-founder before at Genentech sind 1981) |
Company Founder |
Coherus BioSciences Inc. |
United States (USA) |
Buis, Philipp (Coulter Partners 201703– Executive Director in Zurich before Jauch Assoc + Ward Howell/Neumann Intl) |
President/Director/Head Business Group/Unit/Division |
Coulter Partners (The Coulter Partnership Ltd.) |
Switzerland |
Bujard, Hermann |
n. a. |
University of Heidelberg (Ruperto Carola) |
Germany |
Bukowski, Nick (Schauenburg 201301 Business Development Manager at Almsco) |
Business Development Manager / Strategy Manager |
Schauenburg (Group) |
United Kingdom (GB) |
Bulc, Ales (Global Bioenergies 201606 CEO of Global Bioenergies GmbH) |
Chief Executive Officer (CEO) |
Global Bioenergies (Group) |
Germany |
Bulcke, Paul (Nestlé 201402 CEO) |
Chief Executive Officer (CEO) |
Nestlé (Group) |
Switzerland |
Bull, David (Epigenomics 201703 Director of Marketing) |
Sales Manager / Marketing Manager |
Epigenomics (Group) |
United States (USA) |
Buller, Fabian (Neurimmune 201804– CBO before JnJ Innovation + Covagen) |
Chief Business Officer (CBO) |
Neurimmune AG |
Switzerland |
Buller, Ulrich (Fraunhofer 200811 Research Director) |
n. a. |
Fraunhofer (Group) |
Germany |
Bullerdiek, Jörn |
n. a. |
University of Bremen |
Germany |
Bullock, Heidi (Ingenuity 200603) |
n. a. |
Qiagen (Group) |
United States (USA) |
Bulpin, Andrew (Millipore 200812 VP Upstream Bioprocess Business Unit) |
President/Director/Head Business Group/Unit/Division |
Merck (DE) (Group) |
United States (USA) |
Bulthuis, Roel (Inkef Capital 201811– Managing Director + Head Heathcare before Merck M Ventures + Fortis Bank + Devgen) |
Investment Manager |
ABP (Stichting Pensioenfonds) (Group) |
Netherlands |
Bumol, Thomas F. (Lilly 201708 SVP Biotechnology + Immunology Research) |
President/Director/Head Business Group/Unit/Division |
Eli Lilly (Group) |
United States (USA) |
Bundis, Florian (Peqlab 200809) |
n. a. |
Avantor (Group) |
Germany |
Bunge, Dörte (Hamburg (govt) 201208 Investment Manager at Innovationsstarter Hamburg GmbH) |
Investment Manager |
Hamburg (govt region) |
Germany |
Bunger, Maureen (Lonza 201703 Product Manager ADME-Tox Solutions) |
Product Manager (personnel) |
Lonza (Group) |
Switzerland |
Bungers, Simon (Labfolder 201509 Managing Director + Founder) |
Managing Director |
Labforward (Group) |
Germany |
Buono, Stefano (Advanced Accelerator Applications 201402 CEO) |
Chief Executive Officer (CEO) |
Novartis (Group) |
France |
Burckhardt, Andreas (MC Services 201304– Executive Director Corporate Broking before WestLB) |
Public Relations Manager / Investor Relations Manager |
MC Services AG |
Germany |
Burckhardt, Peter E. (Basel Inkubator 201603 CEO) |
Chief Executive Officer (CEO) |
Basel Inkubator (University of Basel + FHNW) |
Switzerland |
Burdack, Christoph (Priaxon AG 201401 CEO) |
Chief Executive Officer (CEO) |
Priaxon AG |
Germany |
Burema, Peter (NextPharma 202101 CEO) |
Chief Executive Officer (CEO) |
NextPharma (Group) |
United Kingdom (GB) |
Burgaezy, Frank (Bruker 201201 President of Bruker AXS division) |
President/Director/Head Business Group/Unit/Division |
Bruker (Group) |
Germany |
Burger, Anne (MedVenture Partners 2002– Director + Breath Therapeutics 201609– CFO + Curetis 201007–2012 CFO) |
Chief Executive Officer (CEO) |
MedVenture Partners GmbH |
Germany |
Burger, Cyrill (PMOD Technologies 201907 CEO) |
Chief Executive Officer (CEO) |
Bruker (Group) |
Switzerland |
Burger, Joachim (Univ Mainz 201211 Professor) |
Professor |
University of Mainz (Johannes Gutenberg University) |
Germany |
Burgermeister, Patrick (Apeiron 201101– Business Development Manager + BioMedPartners before Novartis) |
Business Development Manager / Strategy Manager |
Apeiron (Group) |
Austria |
Burgess, Mike (BMS 201301– SVP Discovery Medicine + Clinical Pharmacology before Roche) |
Research & Development Manager |
Bristol-Myers Squibb (BMS) (Group) |
United States (USA) |
Burgess, Rob (RayBiotech 201408 VP Business Development before Stem Cell Sciences) |
Business Development Manager / Strategy Manager |
RayBiotech Inc. |
United States (USA) |
Burgstaller, Petra (BioM 202001 Senior Manager Start-ups + Funding) |
Cluster Manager |
Bavaria (govt region) |
Germany |
Burian, Rainer C. (PAA Laboratories GmbH 201108 Managing Director) |
Managing Director |
General Electric (Group) |
Austria |
Burkamp, Frank (Almac 201206 Senior Investigator) |
Researcher (industry) |
Almac (Group) |
United Kingdom (GB) |
Burnet, Michael (Synovo GmbH 201109 Managing Director) |
Managing Director |
Synovo GmbH |
Germany |
Burnet, Renate (Synovo GmbH 201710 Business Development) |
Business Development Manager / Strategy Manager |
Synovo GmbH |
Germany |
Burns, Alasdair A. (Microstein LLC 201208 CEO) |
Chief Executive Officer (CEO) |
Microstein LLC |
United States (USA) |
Burns, James W. (Jim) (Casebia Therapeutics 201611– CEO before Sanofi-Genzyme + MassBio) |
Chief Executive Officer (CEO) |
CRISPR Therapeutics (Group) |
United States (USA) |
Burns, Robert F. (4-Antibody 201101– CEO before Affitech CEO before Celldex Therapeutics CEO) |
Chief Executive Officer (CEO) |
Agenus (Group) |
Switzerland |
Burns, Rowena (Manchester Science Partnerships 201208– CEO + 201807 Chair of Health Innovation Manchester) |
Cluster Manager |
Summit (Group) |
United Kingdom (GB) |
Burns, William M. (Roche 200207–200904– CEO Pharma division) |
Chief Executive Officer (CEO) |
Roche (Group) |
Switzerland |
Burow, Martin (GATC Biotech 201011– Head Commercial Operations LifeCodexx AG before Brahms AG Sales Manager Asia) |
Chief Commercial Officer (CCO) |
Eurofins (Group) |
Germany |
Burrows, Jon (Oxford BioDynamics 202011 CEO formerly Expression Pathology + Ventana + Novartis + Chiron) |
Chief Executive Officer (CEO) |
Oxford BioDynamics (Group) |
United Kingdom (GB) |
Busch, Andreas (Bayer 201201–201711 Head Global Drug Discovery at Bayer Healthcare LEFT 11/17) |
President/Director/Head Business Group/Unit/Division |
Bayer (Group) |
Germany |
Buschmann, Helmut (Savira Pharmaceuticals 201210 CSO) |
Chief Executive Officer (CEO) |
Savira Pharmaceuticals GmbH |
Austria |
Bushell, Mike (Syngenta 200502) |
n. a. |
Syngenta (Group) |
Switzerland |
Buss, Tony (MerLion –200707– CEO) |
Chief Executive Officer (CEO) |
MerLion (Group) |
Singapore |
Busse, Falko (Bruker Corp 201805– President of Bruker BioSpin Group joined 2015 before Philips Healthcare) |
President/Director/Head Business Group/Unit/Division |
Bruker (Group) |
Germany |
Busse, Wolf-Dieter (Aerovance 200408– CEO before Bayer SVP Biotech) |
Chief Executive Officer (CEO) |
Aerovance Inc. |
United States (USA) |
Butler, Lynn (Sirenade Pharmaceuticals 200407– CEO before Swentibold before Devgen) |
Chief Executive Officer (CEO) |
KeyNeurotek (Group) |
Germany |
Butscheid, Yulia (Biognosys 201304– Head Strategy + Business Development before Creathor Venture + Novartis) |
Business Development Manager / Strategy Manager |
Biognosys AG |
Switzerland |
Butscher, Philipp (Berliner Effektengesellschaft 201205 Associate at Ventegis Capital AG) |
n. a. |
Berliner Effektengesellschaft (Group) |
Germany |
Buttar, Rabinder (ClinTec 1997– CEO + Founder) |
Chief Executive Officer (CEO) |
ClinTec (Group) |
United Kingdom (GB) |
Butterfield, Stewart (Slack Technologies 202012 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Salesforce (Group) |
United States (USA) |
Buttkereit, Monika (Biotest 201308 Head of Investor Relations) |
Public Relations Manager / Investor Relations Manager |
Creat (Group) |
Germany |
Buyse, Chris (Fund+ 201610 Managing Partner before ThromboGenics 201203 CFO) |
Managing Partner |
Fund+ N.V. |
Belgium |
Büchele, Wolfgang (Linde 201405 designated CEO + Board Chairman of Merck KGaA) |
Chief Executive Officer (CEO) |
Linde (Group) |
Germany |
Büchler, Andrea (Lunaphore 201808 Finance + Business Development) |
Business Development Manager / Strategy Manager |
Lunaphore Technologies S.A. |
Switzerland |
Byczynski, Michael (Eppendorf 200803) |
n. a. |
Eppendorf (Group) |
Germany |
Bügling, Dieter (Polyplan GmbH 200902 Managing Director) |
Managing Director |
Polyplan (Group) |
Germany |
Bühler, Markus (Technologiepark Heidelberg 201504 Startup Support Manager) |
n. a. |
Heidelberg (govt city) |
Germany |
Bülow, Holger (Miltenyi 201901 Press Contact) |
Public Relations Manager / Investor Relations Manager |
Miltenyi Biotec (Group) |
Germany |
Bülow, Sven (Eppendorf 201104 EVP Corporate Developm before Director Eppendorf Biochip Systems) |
Business Development Manager / Strategy Manager |
Eppendorf (Group) |
Germany |
Büntemeyer, Heino (TeutoCell 201105 Executive Board Member) |
Board member, executive |
Xell AG |
Germany |
Bünz, Alexander (Knauer 2006–2014 Managing Director LEFT 2015) |
Managing Director |
Knauer GmbH (Wissenschaftliche Gerätebau Dr. Ing. Herbert Knauer GmbH) |
Germany |
Bürger, Frank (Avida Group 200508 before WGZ-Bank) |
n. a. |
AVIDA Group (Dusseldorf) |
Germany |
Bürger, Mario (GeSiM 200604 Managing Director) |
Managing Director |
GeSiM – Gesellschaft für Silizium-Mikrosysteme mbH |
Germany |
Bürk, Jan-Hendrik (btov Partners 202010 Principal) |
Principal (venture capital) |
btov Partners (b-to-v Partners AG) |
Germany |
Bürk, Matthias (Merck (DE) 201409 Head of Human Resources Germany) |
Human Resources Manager |
Merck (DE) (Group) |
Germany |
Bürling, Philipp (Numaferm GmbH 201702– Managing Director) |
Managing Director |
Numaferm GmbH |
Germany |
Bürmann, Martin (Rittershaus 200809 Mannheim) |
n. a. |
Rittershaus Rechtsanwälte Partnerschaftsgesellschaft mbH |
Germany |
Bürsgens, Federico (GNA Biosolutions 201908 Managing Director + Co-Founder) |
Managing Director |
GNA Biosolutions GmbH |
Germany |
Bütow, Sandra M. (Germany (govt) 201504 Senior Manager MedTech + Medical Biotech + Pharma at GTAI) |
n. a. |
Germany (govt) |
Germany |